HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Federal rulemaking freeze lift linked to HR 9 enactment in Rep. McIntosh subcmte. mark-up.

This article was originally published in The Rose Sheet

Executive Summary

LIFTING OF FEDERAL RULEMAKING FREEZE TIED TO HR 9 ENACTMENT under an amendment offered by Rep. Robert Ehrlich (R-MD) and approved by the House Government Reform/National Economic Growth Subcommittee at a Feb. 8 mark-up of "The Regulatory Transition Act of 1995" (HR 450). The amendment extends the expiration date of the proposed federal regulatory moratorium until the enactment of regulatory reform. The deadline for lifting the rulemaking freeze was July 1, 1995 in the original bill.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001308

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel